Blog

The advancement of medical treatments and therapies within modern healthcare is fundamentally dependent on rigorous clinical research. An essential component ensuring the integrity, safety, and efficacy of this research is the oversight provided by national regulatory bodies. These authorities are critical guardians of public health, implementing and enforcing a comprehensive framework to ensure that all therapeutic treatments meet stringent standards before they are made available to patients.

Clinical trial sites and site management organizations (SMOs), both commercial and within the public health system, are intrinsic to the success (or failure) of clinical trials. While regulatory compliance establishes the ethical and legal framework, a comprehensive approach to quality management system that encompasses quality assurance (QA), quality management (QM), and quality control (QC) ensures the integrity and reliability of research.

Clinical research sites, including clinical trial sites and site management organizations (SMOs), operate within a complex web of regulations designed to safeguard patient welfare and ensure data integrity. Adhering to these regulations – clinical trial regulatory compliance – is not merely a legal obligation; it’s fundamental to conducting ethical, high-quality research that sponsors, regulatory authorities, and patients can trust.

In the complex and vital world of clinical research, where innovation meets risk and opportunity for new medical treatments, a crucial layer of oversight is essential to ensuring patient safety, data integrity. This oversight is provided by the regulatory authorities – the bodies responsible for ensuring that clinical trials are conducted in accordance with ICH-GCP (International Council for Harmonisation's Good Clinical Practice).

Alison Steel, a qualified nurse, has an in-depth understanding of Clinical Research from her role as a healthcare professional and an unexpected introduction into the Industry. Working for the NHS (UK), Alison provides an invaluable perspective as to the current challenges for Clinical Research and how innovation can be the key to making change happen for the better. A driver for change for the better, Alison maintains high standards are the key to success, but outlines how innovation can help deliver and maintain these standards to better meet the needs of the patient population.

London, UK – July 5th, 2024 – IAOCR, the global leader in clinical research competence verification and certification, has released new insights on the alarming rise of fraudulent Clinical Research Associate (CRA) applicants. Recent data reveals that over 40% of CRA applicants are submitting falsified credentials, posing significant risks to the integrity of clinical trials.

Dr Roberto Aguirre is VP, Global Research Director at AGA Clinical Trials, a leading clinical trial site that strives on excellence and collaboration. Roberto’s career led unexpectedly into Clinical Research when he moved to the USA and he has excelled in the field ever since. Learn about Roberto’s journey and valuable insights below.

Danielle Mitchell, CEO and Founder of Black Women in Clinical Research (BWICR), took her own route into clinical research; and has continued to take her own route having established a career in the field. Shocked by the lack of diversity within the Industry, Danielle has chosen to use her observations and experience to drive change and supports black women entering and building careers in the Clinical Research Industry because it matters! Learn more about Danielle’s journey and why she finds it so fulfilling.

Guest Post from Sylvia Wambui – Black Women in Clinical Research. A mid-year review is a chance to step back and take notes of the hits, misses, and learning from the past 6 months and plan how many milestones you need to take in front of you.